Medesist Healthcare
Mumbai, Maharashtra
GST No. 27FWMPS2140N1ZV
TrustSEAL Verified
Call 07942553311 83% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 100 Vial |
| Manufacturer | Hetero |
| Packaging | Vial |
| Dosage Form | Injection |
| Storage | 2* |
| Brand | CIZUMAB 400 MG |
CIZUMAB 400 MG Bevacizumab, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations (see